Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

Antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, repeated thromboembolic phenomena, and thrombocytopenia. The syndrome is believed to be caused by antiphospholipid beta-2-glycoprotein-I (β2GPI)-dependent Abs or anti-β2GPI Abs by themselves. Using a hexapeptide phage display...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Blank, Miri, Shoenfeld, Yehuda, Cabilly, Shmuel, Heldman, Yehudit, Fridkin, Mati, Katchalski-Katzir, Ephraim
Formato: Artigo
Idioma:Inglês
Publicado: The National Academy of Sciences 1999
Assuntos:
Biological Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC21834/
https://ncbi.nlm.nih.gov/pubmed/10220436
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares